C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)
Rayner Intraocular Lenses , Ltd. · Decision date Dec 23, 2025
What did the FDA decide?
FDA records P060011/S043 as a supplement to PMA P060011, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 23, 2025.
FDA approval order statement
a new release-and-wash-bath process to be used during the lens profiling and milling operations
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Dec 23, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P060011/S043
- Regulatory pathway
- PMA supplement
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- HQL
- Decision code
- OK30
- Decision date
- Dec 23, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060011. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060011 · Original PMA
C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)
P060011/S042 · Related supplement
Rayner C-flex 570C, C-flex Aspheric 970C, 600C Aspheric, RayOne Aspheric RAO600C, RayOne Spheric RAO100C and RayOne EMV
P060011/S039 · Related supplement
RayOne EMV Toric
P060011/S043 received
Application receipt date recorded by FDA.
P060011/S043 · FDA decision
30-Day Notice
P060011/S044 · Related supplement
Rayner C-flex 570C, C-flex Aspheric 970C, 600C Aspheric Intraocular lenses, RayOne Aspheric RAO600C, RayOne Spheric RAO1
P060011/S045 · Related supplement
RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
Timeline entries are records held by MedtechLedger for P060011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rayner Intraocular Lenses , Ltd. | PMA approval | May 3, 2007 | FDA | |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Oct 1, 2025 | FDA | |
RayOne EMV ToricP060011/S039 | Rayner Intraocular Lenses , Ltd. | PMA supplement | Oct 9, 2025 | FDA |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Jan 20, 2026 | FDA | |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rayner Intraocular Lenses , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1-2 Sackville Trading Estate,, Sackville Rd., Hove, E. Sussex, BN3 7AN
Sources and methodology
- Original FDA record: P060011/S043
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




